Midgard Science

Ascend

Rockville, MD, United States ascend-adv.com

From their website, Nov 2026

Work here? Claim this listing

About

Ascend is a gene-to-GMP development partner supporting advanced therapy developers from research through commercialization. It serves customers in the US and Europe with work on gene therapies, immunotherapies, oncolytics, and vaccines from sites in Rockville, Alachua, and Munich.

Services

  • Chemistry, manufacturing & controls (CMC)

    Provides CMC support for advanced therapy programs.

  • Process design

    Supports process design for biomanufacturing development programs.

  • Process feasibility

    Evaluates process feasibility for client programs.

  • Upstream and downstream process development

    Develops upstream and downstream processes for advanced therapy products.

  • Assay development and qualification

    Develops and qualifies assays for product and process support.

    Assays & in vitro testing

  • Master and working cell & virus banks

    Creates master and working cell and virus banks.

  • Scale-up and engineering runs

    Performs scale-up and engineering runs to move processes toward manufacturing.

  • GMP bulk drug substance

    Manufactures GMP bulk drug substance.

    CDMO: development & manufacturing

  • GMP aseptic fill/finish

    Performs GMP aseptic fill and finish for drug product.

    CDMO: development & manufacturing

  • Analytical lot release testing

    Carries out analytical lot release testing.

    Assays & in vitro testing

  • ICH stability testing

    Performs ICH stability testing for product support.

    Assays & in vitro testing

  • Regulatory guidance & filing

    Provides regulatory guidance and filing support.

  • Platform innovation for AAV processes

    Uses side-by-side platform comparisons and DoE to optimize AAV processes.

  • Gene therapy formulation

    Performs high-throughput and focused formulation screening for gene therapy products, especially AAV.

    Assays & in vitro testing

  • Scalable manufacturing

    Scales processes from small volumes to larger bioreactors and supports downstream workflows, including fill/finish.

    CDMO: development & manufacturing

  • Process development

    Optimizes process conditions for AAV vector manufacturing, oncolytics, immunotherapies, and vaccines.

  • Aseptic fill-finish

    Provides aseptic filling for viral vectors, gene therapies, oncolytics, vaccines, and other liquid biologics.

    CDMO: development & manufacturing

  • Analytics & GMP QC testing

    Offers characterization and release testing, including GMP QC testing for impurities, titer, potency, and related attributes.

    Assays & in vitro testing

  • Viral vector long-read NGS

    Uses Oxford Nanopore long-read sequencing to characterize viral vectors and detect impurities.

  • Potency assay services

    Develops, qualifies, and validates mechanism-driven potency assays for gene therapies and ATMPs.

    Assays & in vitro testing

  • EpyQ® AAV Production System

    Provides a two-plasmid AAV production system for manufacturing support.

  • Master and working cell and virus banks

    Creates master and working cell and virus banks for development and manufacturing programs.

  • Scalable manufacturing process development

    Develops scalable manufacturing processes from small scale to larger bioreactors.

    CDMO: development & manufacturing

Turnaround
2-day turnaround
What to send
As little as ~5E9 vg for AAV · Minimal sample requirements · Low volume

Capabilities

Assays and studies
AAV · Fill-finish · Process development · NGS · Bioreactors · Lentivirus · ELISA · Cell therapy · Stability studies · ddPCR · Automated immunoassay · Dynamic light scattering
16 moreSEC · Full/empty methods · Capsid concentration · In vitro cell-based relative potency assays · Vector genome concentration · Infectious titre · Residual DNA testing · Subvisible particles · Endotoxin · NGS impurity characterization · Potency assays · VG/mL · %full capsid · Encapsidated genome length (NGS) · Particle aggregation · Visible particles
Scale and capacity
2L to 500L · 0.5L to 500L · 10 L scale · Up to 3000 vials per batch · 200 to 3,000 vials per lot · Up to 10,000 vials per lot · 57500 sqft GMP manufacturing facility in Alachua, Florida · 57000 sqft GMP Quality Control facility in Munich, Germany · 72000 sqft GMP manufacturing & testing facility in Rockville, Maryland · Three key locations · In-house fill/finish in two of its United States locations
Therapeutic areas
Gene therapy · Cell and gene therapy · Advanced therapies · CNS-directed gene therapies · Immunotherapies · Vaccines

Instruments and platforms

  • Flexicon FPC50W
  • Oxford Nanopore
  • Stirred-tank bioreactors
  • Orbital shaking bioreactors
  • Rocking bioreactors
  • Long-read NGS
  • Droplet digital PCR (ddPCR)
  • Automated immunoassay
  • Dynamic light scattering
  • SEC

Modalities and species

Modalities
Viral vector · Cell therapy · Vaccine · Plasmid DNA
Species and models
HEK293 cell line · Oxford Nanopore

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001Self-reported

    Scope: quality management system

  • GMPSelf-reported

Company

Type
CRDMO

Locations

Address
9800 Medical Center Drive • Building D Rockville, MD 20850 USA
Sites
Rockville, USA · Alachua, USA · Munich, Germany
Serves
United States, Europe, global

Similar labs

Work here? Claim this listing